OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.580
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.550
-0.030 (-1.90%)
After-hours: Apr 28, 2026, 4:55 PM EDT
OKYO Pharma Employees
OKYO Pharma had 4 employees as of March 31, 2025. The number of employees increased by 1 or 33.33% compared to the previous year.
Employees
4
Change (1Y)
1
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,153,335
Market Cap
82.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Sangamo Therapeutics | 142 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| XBiotech | 85 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
OKYO News
- 21 days ago - OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting - GlobeNewsWire
- 5 weeks ago - OKYO Pharma Announces Chairman and Founder Acquires Shares - GlobeNewsWire
- 5 weeks ago - OKYO Pharma Announces Director Acquires Shares - GlobeNewsWire
- 5 weeks ago - OKYO Pharma Announces Chief Development Officer and Director Acquires Shares - GlobeNewsWire
- 5 weeks ago - OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain - GlobeNewsWire
- 2 months ago - OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress - GlobeNewsWire
- 2 months ago - OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares - GlobeNewsWire
- 2 months ago - OKYO Pharma Announces Public Offering of Ordinary Shares - GlobeNewsWire